NCT04743661 2026-02-05
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Pediatric Brain Tumor Consortium
Phase 2 Active not recruiting
Pediatric Brain Tumor Consortium
New Approaches to Neuroblastoma Therapy Consortium
Stanford University